Internal Medicine, Pulmonary Disease · Westminster, CA
NPI
1043401698
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
14120 Beach Blvd 101
Westminster, CA, 92683
Phone (714) 887-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
1,834 services
Medicare patients, 2024
184
Average age 78
Drug cost, 2024
$2.4M
4,556 prescriptions
Company payments, 2025
$173K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David N Pham was code 99214 (office e&m - established), 926 times for 178 patients. In total David N Pham billed 1,834 services in 20 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 926 | 178 | $104.86 | $97K |
| 96374 Injection Administration | Office | 227 | 28 | $32.79 | $7,442 |
| 94726 Pulmonary Function Testing | Office | 61 | 58 | $50.76 | $3,096 |
| 94375 Pulmonary Function Testing | Office | 55 | 54 | $34.86 | $1,917 |
| 94727 Pulmonary Function Testing | Office | 55 | 54 | $40.33 | $2,218 |
| 94728 Pulmonary Function Testing | Office | 55 | 54 | $40.02 | $2,201 |
| 94729 Pulmonary Function Testing | Office | 55 | 54 | $51.79 | $2,848 |
| 94200 Pulmonary Function Testing | Office | 55 | 54 | $13.52 | $743 |
| G0008 Administration of influenza virus vaccine | Office | 47 | 46 | $34.33 | $1,614 |
| 90653 Vaccine Product | Office | 38 | 38 | $79.86 | $3,035 |
| 99204 Office E&M - New | Office | 32 | 32 | $138.20 | $4,422 |
| 96372 Injection Administration | Office | 23 | 11 | $12.59 | $290 |
By year: 2022 $190K for 2,344 services; 2023 $181K for 4,213 services; 2024 $129K for 1,834 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 2,312 | 161 | $11.76 | $27K |
Medicare prescription drug claims, 2024
In 2024, the drug David N Pham prescribed most often to Medicare patients was Breztri Aerosphere (Budesonide/Glycopyr/Formoterol), with 646 prescriptions and refills. In total David N Pham wrote 4,556 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 646 | 1,018 | 153 | $630K |
| Montelukast Sodium Generic | 255 | 614 | 68 | $2,002 |
| Fluticasone Propionate Generic | 252 | 526 | 77 | $2,836 |
| Ventolin Hfa Albuterol Sulfate | 207 | 327 | 49 | $20K |
| Atorvastatin Calcium Generic | 149 | 389 | 43 | $1,185 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 129 | 259 | 48 | $11K |
| Levocetirizine Dihydrochloride Generic | 122 | 316 | 38 | $1,196 |
| Triamcinolone Acetonide Generic | 113 | 189 | 25 | $1,054 |
| Famotidine Generic | 108 | 273 | 34 | $817 |
| Dupixent Syringe Dupilumab | 95 | 95 | 18 | $360K |
| Gabapentin Generic | 93 | 160 | 20 | $754 |
| Meloxicam Generic | 87 | 198 | 28 | $343 |
| Metformin Hcl Generic | 71 | 204 | 24 | $373 |
| Tamsulosin Hcl Generic | 62 | 162 | 18 | $485 |
| Restasis Cyclosporine | 58 | 127 | 15 | $77K |
Brand drugs: - claims; generic drugs: 3,023 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David N Pham $173K ($173K in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $152K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 159 | $152K |
| GlaxoSmithKline, LLC. GSK | 51 | $20K |
| Genzyme Corporation SNY | 13 | $444 |
| Verona Pharma, Inc. VRNA | 1 | $102 |
| Insmed, Inc. INSM | 4 | $83.3 |
| Aimmune Therapeutics, Inc. | 3 | $71.73 |
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $67.65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.89 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $32.01 |
| CONMED Corporation CNMD | 1 | $28.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.